Japan's IP High Court is advocating new rules on when patent term extensions for pharmaceuticals should be granted. Shintaro Yamada of Shiga International Patent Office explains what they mean in ...
Min Son of Hanol IP & Law explains that the regime will limit extensions to one patent per approval and cap extended periods at 14 years from the date of marketing authorisation A new patent term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback